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Comparison of the Etest and a microbroth dilution
system (Sceptor) to a reference agar dilution method
for susceptibility testing of Bilophila wadsworthia
Ulrike K. Schumacher
Department of Medical Microbiology, Institute of Hygiene, University of Tiibingen, Tiibingen,
Germany
Objective: To compare the Etest and a microbroth dilution system (Sceptor) to a reference agar dilution method for
susceptibility testing of Bilophila wadsworthia.
Methods: The susceptibility of 15 clinical isolates of Bilophila wadsworthia was determined by the National Committee
for Clinical laboratory Standards (NCClS) agar dilution method using triphenyltetrazolium chloride for endpoint
determination. The results were compared with the results obtained by the E test and a commercial microbroth dilution
system (Sceptor).
Results: Comparison of the MICs obtained by the reference method and the Etest revealed few discrepancies, with
piperacillin and metronidazole being the only exceptions. The overall agreement was 70% within one dilution step. The
discrepancies did not result in major interpretative errors. The overall essential agreement using susceptibility categories
was 98% for the E test and 99% for the microdilution system.
Conclusions: Both methods may be considered as acceptable alternatives for testing individual isolates of B.
wadsworthia.
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INTRODUCTION
Bilophila wadsworthia, a recently described anaerobic,
fastidious, slow-growing, non-sporing, Gram-negative
rod, has mainly been found associated with com-
plicated appendicitis in adults and children [1,2]. It has
also been reported as part of other infectious processes,
such as liver abscess, bacteremia, mandibular osteo-
myelitis, scrotal abscess and pleural empyema, suggest-
ing B. wadsworthia to be a significant clinical pathogen
[3]. The lower human intestinal tract seems to be
the main habitat of B. wadsworthia; the species was
recovered from the feces of60% ofsubjects studied [1,2].
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Due to its fastidious properties, antimicrobial
susceptibility testing of B. wadsworthia by the agar
dilution method has to be performed on supplemented
brucella agar as recommended by the National Com-
mittee for Clinical Laboratory Standards (NCCLS) as
an approved standard [4]. Further addition of 1%
pyruvate allows improved growth ofB. wadsworthia, and
recent studies have indicated that addition of pyruvate
has no effect on susceptibility results [5]. In contrast
to earlier publications indicating significant resistance
of B. wadsworthia to several f3-lactam antibiotics, more
recent studies, using viability indicators such as tri-
phenyltetrazolium cWoride (TTC) for discrimination
between haze growth producing spheroblasts and viable
cells, revealed lower MICs, especially for imipenem and
cefoxitin [5,6].
The NCCLS recommends susceptibility testing of
certain anaerobes, including B. wadsworthia, in cases of
recurrent or refractory bacteremia, osteomyelitis, iso-
lation ofa microorganism from any normally sterile site
or an infection not responding to empirical antibiotic
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treatment [7]. The modified reference agar dilution
technique required for testing B. wadsworthia is not
suitable for daily practice. Therefore, more simple and
reliable methods for testing individual isolates of B.
wadsworthia have to be designed. In a recent comparison
of commercial microbroth dilution systems, a 98% rate
of essential agreement (complete agreement plus minor
interpretative errors) of the Sceptor anaerobe MIC
panel with the reference agar dilution method was
found [8]. Recently, the Etest has been evaluated for
testing anaerobes other than B. wadsworthia [9,10]. The
present study compared the MICs obtained with the
E test to the MICs determined by the reference agar
dilution method modified by supplementation with 1%
pyruvate, anaerobic incubation of96 h and an endpoint
determination using TTC. A comparison was also
made of the results obtained by the three methods by
using interpretative susceptibility categories.
MATERIALS AND METHODS
Fifteen clinical isolates of B. wadsworthia and two
reference strains (Bacteroides fragilis ATCC 25285,
Bacteroides thetaiotaomicron ATCC 29471) were tested.
Identification of B. wadsworthia was made by Gram
stain, catalase production, growth and hydrogen sulfide
production on BBE medium, glucose fermentation
(negative), nitrate reduction in PRAS medium and
acetic acid detection by gas-liquid chromatography.
Strains were subcultured and all tests were performed
on supplemented brucella agar (Difco) with 5% sheep
blood, 5 I-tg/mL hemin, 1 I-tg/mL vitamin K and 1%
pyruvic acid (Sigma Chemicals Co.). The antimicrobial
agents tested included penicillin G, cefotaxime (Hoechst
AG, Bad Soden), ampicillin, mezlocillin, metronidazole
(Bayer AG, Leverkusen) amoxicillinlclavulanic acid
(fixed ratio 2: 1; SmithKline Beecham, Miinchen),
piperacillin (Lederle Arzneimittel GmbH, Wolfrats-
hausen), chloramphenicol (Boehringer Mannheim,
Mannheim), clindamycin (Upjohn, Heppenheim),
erythromycin (Abbott, Wiesbaden) and imipenem
(MSD Sharp & Dohme, Haar). Etest strips were pur-
chased from Difco. The Sceptor system (Anaerobe
MHK/ID panel, Panel No. 4484620; Becton Dickin-
son, Heidelberg) was used for microbroth dilution
testing.
The inoculum was prepared by suspending fresh
colonies (96 h for B. wadsworthia, 48 h for reference
strains) from supplemented brucella agar into test broth
tubes (Sceptor Anaerobe MICIID broth; 4480316;
Becton Dickinson) to achieve an optical density equal
to a no. 1 MacFarland standard. Agar dilution testing
was performed twice as outlined in the Wadsworth
anaerobic bacteriology manual using supplemented
brucella agar with a final inoculum of 105 CFU per spot
[7]. Concentrations of all antimicrobial agents tested
ranged from 0.015 I-tg/mL up to 256 I-tg/mL. MICs
were determined after 96 h of anaerobic incubation
with the aid ofTTC (Sigma) as described elsewhere [5].
Briefly, a 0.2% TTC solution was mixed with 2%
molten agar and dropped over the spots. After 10 min
of aerobic incubation at room temperature, the MICs
were interpreted as the lowest concentration of
antimicrobial agent that permitted the reduction of
TTC to red formazan.
For the Etest, a sterile swab was dipped into the
cell suspension, and then streaked over the entire
surface of the test plate. The plate was incubated under
anaerobic conditions for 4 h before the strip was
applied. MICs were determined after 96 h of anaerobic
incubation by reading the corresponding value listed on
the Etest strip scale, where the inhibition zone
intersected the strip. Although additional interscaled
values are listed on the Etest scale, the results were
scaled up to those values corresponding to agar dilution
MICs.
For microbroth dilution testing, 100 I-tL of the cell
suspension was transferred into 10 mL of test broth.
The test was performed as outlined by the manufac-
turer and was read after 96 h of anaerobic incubation.
Because only five concentrations of each antimicrobial
agent were tested in the Sceptor system, the results were
categorized according to the manufacturer"s instruct-
ions based on DIN recommended breakpoints. To
facilitate comparison, the agar dilution and Etest
results were also classified in accordance with DIN
recommended categories [11] (with metronidazole,
susceptible s4; intermediate 8-16 I-tg/mL; resistant ~32
I-tg/mL). Testing for production of 13-lactamase was
performed by using nitrocefin disks and a test duration
of 1 h (cefinase, Becton Dickinson, Heidelberg).
RESULTS AND DISCUSSION
The MICs of the quality control strains obtained by the
agar dilution method after 96 h ofanaerobic incubation
were within the limits required by the NCCLS,
indicating that prolonged incubation and supple-
mentation with pyruvate have no major effect on the
results [4].
Metronidazole, clindamycin and imipenem were
the most active compounds against B. wadsworthia
(MICs sO.5 I-tg/mL). Chloramphenicol was also very
active, with MICs of s4 I-tg/mL. While all strains
showed reduced susceptibility to penicillin G (MICs
0.25-4 I-tg/mL), ampicillin, mezlocillin and piperacillin
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proved to be less active. Ampicillin and mezlocillin
were active against only one different strain each (MICs
s8 }-tg/mL). Addition of clavulanic acid to amoxicillin
resulted in MICs comparable to that of penicillin G
(MICs between 1 and 4I-lg/mL; Table 1). The break-
point of4 }-tg/mL for penicillin and ampicillin is assumed
to differentiate between (3-lactamase-producing and
non producing strains. In this study none of the isolates
had penicillin MICs of>4 }-tg/mL, but 13 of 15 strains
showed ampicillin MICs of<!o16 }-tg/mL. Although the
latter results suggested the strains to be (3-lactamase
producers, no enzyme activity was detectable by the
nitrocefin disk method, by which Baron and coworkers
had obtained positive results [1]. Similar MICs for
penicillin and ampicillin were reported recently but
with a detection rate for (3-lactamase of 87% of the test
strains [5]. The characteristics of (3-lactamases of B.
wadsworthia, as well as resistance mechanisms to (3-
lactam antibiotics other than (3-lactamase production,
will have to be investigated by further studies.
When the MICs determined by the Etest were
compared with the results obtained by the agar dilution
method, an overall agreement of 70% (results within
one twofold dilution) and 84% (within two dilutions)
was achieved. Major discrepancies were obtained only
with piperacillin and metronidazole (Table 1). With
piperacillin, no inhibition ellipse was readable in the
Etest, although the test was repeated twice. The MICs
obtained by the agar dilution method showed cluster-
ing about the breakpoint of moderately susceptible to
resistant. In contrast, MICs of metronidazole were
found to be very low with both methods, but the
Etest results of nine strains were nearly off-scale. The
tendency of the Etest MICs to be lower than those
measured by the agar dilution method was observed for
anaerobic bacteria other than B. wadsworthia by other
authors [9,10,12]. Especially in the case of metro-
nidazole, susceptibility testing differences in the ino-
culum actually delivered onto the plate, which reach a
full loglO unit, could possibly explain some of these
findings [9].
The broth microdilution method is an NCCLS
recommended technique for susceptibility testing of
anaerobes, although it has some limitations, due to the
inability of some fastidious, slow-growing anaerobes to
multiply in broth media. Despite our own experience
that B. wadsworthia does not grow well in broth, all the
strains tested developed suffIcient growth in the test
panels. MICs obtained with microdilution tests may be
<!o1 twofold dilution lower than with agar dilution [13].
However, 29 of the 35 minor interpretative errors of
the microbroth system in the present study were caused
by higher MICs in microdilution compared to the agar
dilution method. In 25 of these cases the agar dilution
method indicated moderate susceptibility and the
microbroth dilution method indicated resistance. The
relatively high broth dilution MICs may be due to
degradation of the antibiotics during the prolonged
incubation time.
The differences and the discrepancies in deter-
mination of MICs of metronidazole and piperacillin
with the Etest did not result in major interpretative
discrepancies. Using susceptibility categories, the
overall complete agreement was 84% for the Etest
and 66% for the microdilution system. The rates of
essential agreement (complete agreement plus minor
interpretative errors) were 98% and 99%, respectively
(Table 2). Provided that only susceptibility categories
are reported, either system may be acceptable as
an alternative for testing individual isolates of B.
wadsworthia.
Table 1 Comparison of agar dilution and Etest results for 15 strains of Bilophila wadsworthia
Agar dilution ETest
n n
MIC90 Range MIC90 Range within ±1 within ±2
(llg/mL) (llg/mL) dilution dilution
Penicillin G 4 0.25-4 4 0.25-4 15 15
Ampicillin 32 4-32 64 4 to >256 14 14
AmoxicillinlClavulanic acid 4 1~4 2 0.25-2 12 15
Piperacillin 64 32-64 >256 >256
° °Mezlocillin 64 8-64 ND ND
Cefotaxime 4 1-4 4 0.5-4 10 15
Metronidazole 0.06 ,;0.015-0.06 0.015 ,;0.002-0.015 4 6
Chloramphenicol 4 2-4 16 1-16 13 15
Clindamycin 0.125 ",0.015-0.25 0.25 0.03-0.5 11 14
Erythromycin 16 4-16 16 4-16 15 15
Imipenem 0.25 0.03-0.5 0.125 0.125-0.5 11 14
ND: not done.
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Table 2 Comparison of results obtained by agar dilution, Etest and microbroth dilution for 15 B.wadsworthia strains
DiscrepanCies Agreement (%)
None Minor Major
Antimicrobial agent ( number of strains) Complete Essential
Penicillin G AD/ET 14 1 93 100
AD/BD 12 3 80 100
Ampicillin AD/ET 15 100 100
AD/BD 9 6 60 100
Amoxicillin/ AD/ET 12 3 SO 100
clavulanic acid AD/BD 11 3 73 93
PiperacilJin AD/ET 8 7 53 100
AD/BD 7 8 47 100
MezlocilJin AD/BD 8 7 53 JOO
Cefotaxime AD/ET 8 7 53 100
AD/BD 12 3 80 100
Erythromycin AD/ET 11 4 73 100
AD/BD 10 5 66.6 100
Clindamycin AD/ET 15 100 100
AD/BD 15 100 100
Metronidazole AD/ET 15 100 100
AD/BD 15 100 100
Chloramphenicol AD/ET 13 2 86 86
AD/BD 15 100 100
Irl1lpeneIll AD/ET 15 100 100
AD/ET =agar dilution versus Etest; AD/HD =agar dilution versus microbroth dilution (Sceptor system).
Minor discrepancy =difference between moderately susceptible and either susceptible or resistant.
Major discrepancy=agar dilution indicates susceptibility and other method indicates resistance.
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